Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Remuneration Information 2023

Jan 24, 2023

61842_rns_2023-01-24_4af85fe7-f7e0-42f7-ab7c-ba1e735f9396.pdf

Remuneration Information

Open in viewer

Opens in your device viewer

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in

Keelakottaiyur Village, Melakottaiyur (Post)

January 24, 2023

The BSE Limited

Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051

Scrip Code: 541540 Dear Sir / Madam,

Scrip Code: SOLARA

Sub: Outcome of Nomination and Remuneration Committee (“NRC”) meeting

In compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, we wish to inform you that Nomination and Remuneration Committee of the Board at its meeting held today i.e., January 24, 2023, had approved the grant of 94600 ESOP options to eligible employees under the “SOLARA EMPLOYEE STOCK OPTION PLAN – 2018”

This is for your information and appropriate dissemination.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2023.01.24 12:14:54 +05'30'

S. Murali Krishna

Company Secretary

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942